Wall Street Analysts Believe Cytek Biosciences (CTKB) Could Rally 47.61%: Here's is How to Trade

Shares of Cytek Biosciences, Inc. (CTKB) have gained 0.7% over the past four weeks to close the last trading session at $6.91, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$10.20 indicates a potential upside of 47.6%.The mean estimate comprises five short-term price targets with a standard deviation of $1.10. While the lowest estimate of$9 indicates a 30.3% increase from the ...